Top

Published in:

Open Access 01-12-2018 | Commentary

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants

Authors: Alimuddin Zumla, Ibrahim Abubakar

Published in: BMC Medicine | Issue 1/2018

Abstract

By the end of 2017, an estimated 68.5 million people were displaced from their homes worldwide, of whom 25.4 million were refugees. The transmission and globalization of multi-drug resistant tuberculosis during refugee migration is a now priority issue in the public health agenda. Political and scientific commitment at the highest national and international levels will be critical to intensifying action in promoting improved health services for migrants and refugees.

UNHCR The UN Refugee Agency. Global Trends: Forced Displaced in 2017. http://www.unhcr.org/5b27be547.pdf. Accessed 5 Sept 2018.

Dhavan P, Dias HM, Creswell J, Weil D. An overview of tuberculosis and migration. Int J Tuberc Lung Dis. 2017;21:610–23.CrossRef

Zumla A, Azhar EI, Hui DS, Shafi S, Petersen E, Memish ZA. Global spread of antibiotic-resistant bacteria and mass-gathering religious events. Lancet Infect Dis. 2018;18(5):488–90.CrossRef

Nellums LB, Thompson H, Holmes A, Castro-Sánchez E, Otter JA, Norredam M, Friedland JS, Hargreaves S. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(7):796–811.CrossRef

World Health Organization. Global Tuberculosis Report 2018. Geneva: WHO; 2018. http://www.who.int/tb/publications/global_report/en/. Accessed 28 Sept 2018

World Health Organization. The End TB Strategy: Global Strategy and Targets for Tuberculosis Prevention, Care and Control after 2015. Geneva: WHO; 2015. http://www.who.int/tb/post2015_strategy/en/. Accessed 4 Oct 2018

Pareek M, Baussano I, Abubakar I, Dye C, Lalvani A. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis. 2012;18:1422–9.CrossRef

Jackson C, Abubakar I. Ending tuberculosis in risk groups in Europe: challenges from travel and population movement. Euro Surveill. 2017;22(12). https://doi.org/10.2807/1560-7917.ES.2017.22.12.30489.

Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Ward B, Teixeira V, Gratziou C, Migliori GB. Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease. Eur Respir J. 2016;47(5):1345–7.CrossRef

10.

The price of a pandemic 2017. All Party Parliamentary group on Global TB Web: http://www.tbonline.info/posts/2017/11/26/price-pandemic-2017/. Accessed 4 Oct 2018. http://media.wix.com/ugd/309c93_f0731d24f4754cd4a0ac0d6f6e67a526.pdf. Accessed 4 Oct 2018.

11.

Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, Mfinanga S, Kapata N, Mwaba P, McHugh TD, Ippolito G, Migliori GB, Maeurer MJ, Zumla A. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018;18(7):e183–98.CrossRef

12.

Khan MS, Osei-Kofi A, Omar A, Kirkbride H, Kessel A, Abbara A, Heymann D, Zumla A, Dar O. Pathogens, prejudice, and politics: the role of the global health community in the European refugee crisis. Lancet Infect Dis. 2016;16(8):e173–7. https://doi.org/10.1016/S1473-3099(16)30134-7.CrossRefPubMed

13.

Zignol M, Dara M, Dean AS, Falzon D, Dadu A, Kremer K, et al. Drug-resistant tuberculosis in the WHO European region: an analysis of surveillance data. Drug Resist Updat. 2013;16:108e15.CrossRef

14.

Lönnroth K, Mor Z, Erkens C, Bruchfeld J, Nathavitharana RR, van der Werf MJ, Lange C. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points. Int J Tuberc Lung Dis. 2017;21:624–37.CrossRef

15.

Hargreaves S, Lönnroth K, Nellums LB, Olaru ID, Nathavitharana RR, Norredam M, Friedland JS. Multidrug-resistant tuberculosis and migration to Europe. Clin Microbiol Infect. 2017;23:141–6.CrossRef

16.

Dahle UR, Eldholm V, Winje BA, Mannsåker T, Heldal E. Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country. Am J Respir Crit Care Med. 2007;176(9):930–5.CrossRef

17.

Pescarini JM, Simonsen V, Ferrazoli L, Rodrigues LC, Oliveira RS, Waldman EA, Houben R. Migration and tuberculosis transmission in a middle-income country: a cross-sectional study in a central area of São Paulo, Brazil. BMC Med. 2018;16:62. https://doi.org/10.1186/s12916-018-1055-1.CrossRefPubMedPubMedCentral

18.

Nellums LB, Rustage K, Hargreaves S, Friedland JS. Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis. BMC Med. 2018;16:27. https://doi.org/10.1186/s12916-017-1001-7.CrossRefPubMedPubMedCentral

19.

Zumla A, Petersen E. The historic and unprecedented United Nations General Assembly High Level Meeting on Tuberculosis (UNGA-HLM-TB) – ‘United to End TB: An Urgent Global Response to a Global Epidemic’. Int J Infect Dis. 2018;75:118–20.CrossRef

20.

United Nations 2018. Political Declaration on the Fight against Tuberculosis. Co-facilitators’ revised text. United to End Tuberculosis: An Urgent Global Response to a Global Epidemic. https://www.un.org/pga/72/wp-content/uploads/sites/51/2018/09/Co-facilitators-Revised-text-Political-Declaraion-on-the-Fight-against-Tuberculosis.pdf. Accessed 5 Oct 2018.

21.

World Health Organization. Joint Initiative ‘FIND. TREAT. ALL. #EndTB”. http://www.who.int/tb/joint-initiative/en/. Accessed 7 Oct 2018.

Title: Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants
Authors: Alimuddin Zumla
Ibrahim Abubakar
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Medicine / Issue 1/2018
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-018-1218-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Effect of 24-month physical activity on cognitive frailty and the role of inflammation: the LIFE randomized clinical trial

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma

Hepatitis B in Moroccan-Dutch: a quantitative study into determinants of screening participation

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation

Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study

Musculoskeletal conditions may increase the risk of chronic disease: a systematic review and meta-analysis of cohort studies